Logo image of IMCD.AS

IMCD NV (IMCD.AS) Stock Fundamental Analysis

AMS:IMCD - Euronext Amsterdam - NL0010801007 - Common Stock - Currency: EUR

117.05  -2.45 (-2.05%)

Fundamental Rating

6

Taking everything into account, IMCD scores 6 out of 10 in our fundamental rating. IMCD was compared to 16 industry peers in the Trading Companies & Distributors industry. While IMCD belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. IMCD is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year IMCD was profitable.
In the past year IMCD had a positive cash flow from operations.
Each year in the past 5 years IMCD has been profitable.
In the past 5 years IMCD always reported a positive cash flow from operatings.
IMCD.AS Yearly Net Income VS EBIT VS OCF VS FCFIMCD.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

1.2 Ratios

IMCD has a better Return On Assets (5.70%) than 87.50% of its industry peers.
The Return On Equity of IMCD (12.57%) is better than 87.50% of its industry peers.
Looking at the Return On Invested Capital, with a value of 8.08%, IMCD belongs to the top of the industry, outperforming 81.25% of the companies in the same industry.
IMCD had an Average Return On Invested Capital over the past 3 years of 9.57%. This is in line with the industry average of 7.87%.
Industry RankSector Rank
ROA 5.7%
ROE 12.57%
ROIC 8.08%
ROA(3y)7.11%
ROA(5y)6.42%
ROE(3y)16.08%
ROE(5y)14.41%
ROIC(3y)9.57%
ROIC(5y)8.66%
IMCD.AS Yearly ROA, ROE, ROICIMCD.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

With an excellent Profit Margin value of 5.89%, IMCD belongs to the best of the industry, outperforming 87.50% of the companies in the same industry.
IMCD's Profit Margin has improved in the last couple of years.
The Operating Margin of IMCD (8.99%) is better than 87.50% of its industry peers.
In the last couple of years the Operating Margin of IMCD has grown nicely.
With a decent Gross Margin value of 22.49%, IMCD is doing good in the industry, outperforming 62.50% of the companies in the same industry.
In the last couple of years the Gross Margin of IMCD has grown nicely.
Industry RankSector Rank
OM 8.99%
PM (TTM) 5.89%
GM 22.49%
OM growth 3Y0.9%
OM growth 5Y6.54%
PM growth 3Y-0.83%
PM growth 5Y7.95%
GM growth 3Y1.7%
GM growth 5Y2.81%
IMCD.AS Yearly Profit, Operating, Gross MarginsIMCD.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

5

2. Health

2.1 Basic Checks

IMCD has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, IMCD has more shares outstanding
The number of shares outstanding for IMCD has been increased compared to 5 years ago.
Compared to 1 year ago, IMCD has an improved debt to assets ratio.
IMCD.AS Yearly Shares OutstandingIMCD.AS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
IMCD.AS Yearly Total Debt VS Total AssetsIMCD.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

IMCD has an Altman-Z score of 3.37. This indicates that IMCD is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.37, IMCD is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
IMCD has a debt to FCF ratio of 7.15. This is a slightly negative value and a sign of low solvency as IMCD would need 7.15 years to pay back of all of its debts.
IMCD's Debt to FCF ratio of 7.15 is fine compared to the rest of the industry. IMCD outperforms 62.50% of its industry peers.
A Debt/Equity ratio of 0.63 indicates that IMCD is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.63, IMCD is in line with its industry, outperforming 43.75% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 7.15
Altman-Z 3.37
ROIC/WACC1.22
WACC6.64%
IMCD.AS Yearly LT Debt VS Equity VS FCFIMCD.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.3 Liquidity

IMCD has a Current Ratio of 1.98. This is a normal value and indicates that IMCD is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of IMCD (1.98) is comparable to the rest of the industry.
A Quick Ratio of 1.29 indicates that IMCD should not have too much problems paying its short term obligations.
The Quick ratio of IMCD (1.29) is better than 75.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.98
Quick Ratio 1.29
IMCD.AS Yearly Current Assets VS Current LiabilitesIMCD.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 10.57% over the past year.
The Earnings Per Share has been growing by 21.23% on average over the past years. This is a very strong growth
The Revenue has been growing slightly by 6.41% in the past year.
The Revenue has been growing by 14.91% on average over the past years. This is quite good.
EPS 1Y (TTM)10.57%
EPS 3Y24.2%
EPS 5Y21.23%
EPS Q2Q%-3.47%
Revenue 1Y (TTM)6.41%
Revenue growth 3Y13.03%
Revenue growth 5Y14.91%
Sales Q2Q%7.52%

3.2 Future

The Earnings Per Share is expected to grow by 14.61% on average over the next years. This is quite good.
IMCD is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.40% yearly.
EPS Next Y85.49%
EPS Next 2Y28.3%
EPS Next 3Y18.56%
EPS Next 5Y14.61%
Revenue Next Year35.8%
Revenue Next 2Y15.63%
Revenue Next 3Y12.07%
Revenue Next 5Y9.4%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
IMCD.AS Yearly Revenue VS EstimatesIMCD.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B
IMCD.AS Yearly EPS VS EstimatesIMCD.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6 8

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 31.98, IMCD can be considered very expensive at the moment.
IMCD's Price/Earnings is on the same level as the industry average.
When comparing the Price/Earnings ratio of IMCD to the average of the S&P500 Index (26.29), we can say IMCD is valued slightly more expensively.
IMCD is valuated rather expensively with a Price/Forward Earnings ratio of 19.43.
The rest of the industry has a similar Price/Forward Earnings ratio as IMCD.
IMCD is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.17, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 31.98
Fwd PE 19.43
IMCD.AS Price Earnings VS Forward Price EarningsIMCD.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of IMCD is on the same level as its industry peers.
Based on the Price/Free Cash Flow ratio, IMCD is valued a bit more expensive than the industry average as 62.50% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 27.37
EV/EBITDA 14.86
IMCD.AS Per share dataIMCD.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
IMCD has an outstanding profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as IMCD's earnings are expected to grow with 18.56% in the coming years.
PEG (NY)0.37
PEG (5Y)1.51
EPS Next 2Y28.3%
EPS Next 3Y18.56%

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.79%, IMCD has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 2.78, IMCD has a dividend in line with its industry peers.
IMCD's Dividend Yield is slightly below the S&P500 average, which is at 2.38.
Industry RankSector Rank
Dividend Yield 1.79%

5.2 History

The dividend of IMCD is nicely growing with an annual growth rate of 22.38%!
Dividend Growth(5Y)22.38%
Div Incr Years0
Div Non Decr Years0
IMCD.AS Yearly Dividends per shareIMCD.AS Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

45.88% of the earnings are spent on dividend by IMCD. This is a bit on the high side, but may be sustainable.
IMCD's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP45.88%
EPS Next 2Y28.3%
EPS Next 3Y18.56%
IMCD.AS Yearly Income VS Free CF VS DividendIMCD.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
IMCD.AS Dividend Payout.IMCD.AS Dividend Payout, showing the Payout Ratio.IMCD.AS Dividend Payout.PayoutRetained Earnings

IMCD NV

AMS:IMCD (6/2/2025, 7:00:00 PM)

117.05

-2.45 (-2.05%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)04-25 2025-04-25
Earnings (Next)07-30 2025-07-30
Inst Owners75.23%
Inst Owner ChangeN/A
Ins Owners1.7%
Ins Owner ChangeN/A
Market Cap6.92B
Analysts79.13
Price Target162.12 (38.5%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.79%
Yearly Dividend2.2
Dividend Growth(5Y)22.38%
DP45.88%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-4.48%
Min EPS beat(2)-15.97%
Max EPS beat(2)7.01%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.83%
Min Revenue beat(2)-2.59%
Max Revenue beat(2)-1.07%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.93%
PT rev (3m)-3.36%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-2.01%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.2%
Revenue NY rev (3m)-1.6%
Valuation
Industry RankSector Rank
PE 31.98
Fwd PE 19.43
P/S 1.46
P/FCF 27.37
P/OCF 24.78
P/B 3.13
P/tB N/A
EV/EBITDA 14.86
EPS(TTM)3.66
EY3.13%
EPS(NY)6.02
Fwd EY5.15%
FCF(TTM)4.28
FCFY3.65%
OCF(TTM)4.72
OCFY4.04%
SpS79.98
BVpS37.45
TBVpS-6.68
PEG (NY)0.37
PEG (5Y)1.51
Profitability
Industry RankSector Rank
ROA 5.7%
ROE 12.57%
ROCE 11.09%
ROIC 8.08%
ROICexc 9.36%
ROICexgc 44.32%
OM 8.99%
PM (TTM) 5.89%
GM 22.49%
FCFM 5.35%
ROA(3y)7.11%
ROA(5y)6.42%
ROE(3y)16.08%
ROE(5y)14.41%
ROIC(3y)9.57%
ROIC(5y)8.66%
ROICexc(3y)10.67%
ROICexc(5y)9.54%
ROICexgc(3y)40.09%
ROICexgc(5y)35.52%
ROCE(3y)14.12%
ROCE(5y)13.14%
ROICexcg growth 3Y11.47%
ROICexcg growth 5Y12.83%
ROICexc growth 3Y2.19%
ROICexc growth 5Y4.08%
OM growth 3Y0.9%
OM growth 5Y6.54%
PM growth 3Y-0.83%
PM growth 5Y7.95%
GM growth 3Y1.7%
GM growth 5Y2.81%
F-Score5
Asset Turnover0.97
Health
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 7.15
Debt/EBITDA 2.49
Cap/Depr 19.36%
Cap/Sales 0.56%
Interest Coverage 6.94
Cash Conversion 49.71%
Profit Quality 90.84%
Current Ratio 1.98
Quick Ratio 1.29
Altman-Z 3.37
F-Score5
WACC6.64%
ROIC/WACC1.22
Cap/Depr(3y)23.75%
Cap/Depr(5y)23.21%
Cap/Sales(3y)0.62%
Cap/Sales(5y)0.61%
Profit Quality(3y)103.46%
Profit Quality(5y)114.83%
High Growth Momentum
Growth
EPS 1Y (TTM)10.57%
EPS 3Y24.2%
EPS 5Y21.23%
EPS Q2Q%-3.47%
EPS Next Y85.49%
EPS Next 2Y28.3%
EPS Next 3Y18.56%
EPS Next 5Y14.61%
Revenue 1Y (TTM)6.41%
Revenue growth 3Y13.03%
Revenue growth 5Y14.91%
Sales Q2Q%7.52%
Revenue Next Year35.8%
Revenue Next 2Y15.63%
Revenue Next 3Y12.07%
Revenue Next 5Y9.4%
EBIT growth 1Y-0.8%
EBIT growth 3Y12.24%
EBIT growth 5Y19.26%
EBIT Next Year27.33%
EBIT Next 3Y13.21%
EBIT Next 5Y13.77%
FCF growth 1Y-33.93%
FCF growth 3Y12.49%
FCF growth 5Y10.07%
OCF growth 1Y-33.52%
OCF growth 3Y12.47%
OCF growth 5Y9.9%